Amgen Inc
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen Restructuring & Asset Impairment Expense by Quarter
Restructuring & Asset Impairment Expense (legacy) ($M) ($M)
Amgen Restructuring & Asset Impairment Expense: -$52M in Q4 2015. No newer figure appears in the documents we track.
Where the Q4 2015 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2018-02-13) ↗
Reported in Form 10-K Restructuring Note (XBRL).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring & Asset Impairment Expense (legacy) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | -52 | – | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2015 | Sep 30, 2015 | 11 | – | 10-Q FY2015 (XBRL) ↗ |
| Q2 2015 | Jun 30, 2015 | 63 | – | 10-Q FY2015 (XBRL) ↗ |
| Q1 2015 | Mar 31, 2015 | 92 | – | 10-Q FY2015 (XBRL) ↗ |
Cite this data
StockData. (2026). Amgen Restructuring & Asset Impairment Expense ($M), quarterly Q1 2015–Q4 2015 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/restruct-impair-exp
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.